The Japan Times - US abortion ruling threatens access to arthritis drug

EUR -
AED 4.313468
AFN 77.598705
ALL 96.698386
AMD 447.792527
ANG 2.102883
AOA 1077.044807
ARS 1692.205144
AUD 1.764354
AWG 2.114155
AZN 2.001365
BAM 1.955767
BBD 2.361861
BDT 143.307608
BGN 1.957508
BHD 0.442093
BIF 3466.042156
BMD 1.17453
BND 1.514475
BOB 8.102865
BRL 6.365607
BSD 1.17268
BTN 106.04923
BWP 15.537741
BYN 3.457042
BYR 23020.795811
BZD 2.358461
CAD 1.618445
CDF 2630.948518
CHF 0.934916
CLF 0.027253
CLP 1069.11676
CNY 8.28573
CNH 8.284609
COP 4466.125466
CRC 586.590211
CUC 1.17453
CUP 31.125056
CVE 110.26316
CZK 24.276491
DJF 208.826515
DKK 7.472132
DOP 74.548756
DZD 152.289758
EGP 55.571073
ERN 17.617956
ETB 183.229742
FJD 2.668303
FKP 0.879936
GBP 0.878351
GEL 3.175767
GGP 0.879936
GHS 13.461775
GIP 0.879936
GMD 85.741137
GNF 10198.829794
GTQ 8.98185
GYD 245.335906
HKD 9.138141
HNL 30.873485
HRK 7.537789
HTG 153.707435
HUF 385.234681
IDR 19536.845016
ILS 3.785271
IMP 0.879936
INR 106.37734
IQD 1536.174363
IRR 49474.161194
ISK 148.465122
JEP 0.879936
JMD 187.756867
JOD 0.832789
JPY 182.950774
KES 151.217476
KGS 102.713135
KHR 4694.921647
KMF 492.719958
KPW 1057.060817
KRW 1731.880759
KWD 0.360233
KYD 0.977284
KZT 611.589793
LAK 25422.575728
LBP 105012.44747
LKR 362.353953
LRD 206.976546
LSL 19.78457
LTL 3.468083
LVL 0.710462
LYD 6.369894
MAD 10.78842
MDL 19.823669
MGA 5194.913303
MKD 61.548973
MMK 2466.385496
MNT 4167.553805
MOP 9.403343
MRU 46.930217
MUR 53.93488
MVR 18.092159
MWK 2033.466064
MXN 21.157878
MYR 4.812408
MZN 75.064681
NAD 19.78457
NGN 1706.088063
NIO 43.15928
NOK 11.906572
NPR 169.679168
NZD 2.023657
OMR 0.451612
PAB 1.17268
PEN 3.948134
PGK 5.054916
PHP 69.43241
PKR 328.640215
PLN 4.225315
PYG 7876.868545
QAR 4.273829
RON 5.092651
RSD 117.378041
RUB 93.579038
RWF 1706.771516
SAR 4.407079
SBD 9.603843
SCR 17.649713
SDG 706.484352
SEK 10.887784
SGD 1.517615
SHP 0.881202
SLE 28.335591
SLL 24629.319496
SOS 668.988835
SRD 45.275842
STD 24310.407882
STN 24.499591
SVC 10.260829
SYP 12986.886804
SZL 19.77767
THB 37.109332
TJS 10.77682
TMT 4.122602
TND 3.428143
TOP 2.827988
TRY 50.011936
TTD 7.957867
TWD 36.804032
TZS 2902.351563
UAH 49.548473
UGX 4167.930442
USD 1.17453
UYU 46.019232
UZS 14127.764225
VES 314.116117
VND 30897.196663
VUV 142.580188
WST 3.259869
XAF 655.946053
XAG 0.018958
XAU 0.000273
XCD 3.174228
XCG 2.113465
XDR 0.815786
XOF 655.946053
XPF 119.331742
YER 280.129715
ZAR 19.820741
ZMK 10572.187233
ZMW 27.059548
ZWL 378.198309
  • NGG

    0.2400

    74.93

    +0.32%

  • SCS

    0.0200

    16.14

    +0.12%

  • GSK

    -0.0700

    48.81

    -0.14%

  • CMSC

    -0.1300

    23.3

    -0.56%

  • RBGPF

    0.0000

    81.17

    0%

  • RIO

    -1.0800

    75.66

    -1.43%

  • AZN

    -0.4600

    89.83

    -0.51%

  • BTI

    -1.2700

    57.1

    -2.22%

  • RYCEF

    -0.2500

    14.6

    -1.71%

  • CMSD

    -0.1500

    23.25

    -0.65%

  • BCE

    0.3100

    23.71

    +1.31%

  • BCC

    0.2500

    76.51

    +0.33%

  • BP

    -0.2700

    35.26

    -0.77%

  • RELX

    0.1000

    40.38

    +0.25%

  • VOD

    0.0500

    12.59

    +0.4%

  • JRI

    -0.0200

    13.7

    -0.15%

US abortion ruling threatens access to arthritis drug
US abortion ruling threatens access to arthritis drug / Photo: Andy Buchanan - POOL/AFP/File

US abortion ruling threatens access to arthritis drug

When Alabama nurse Melissa went to pick up her regular prescription for rheumatoid arthritis last week, she was told the drug was "on hold" while the pharmacist checked she wasn't going to use it to induce an abortion.

Text size:

"He said, 'Well I have to verify if you're on any contraceptives to prevent pregnancy.' The hell you do," she recalled thinking.

Melissa -- who is in her early forties and asked to be identified only by her first name for fear that speaking out might affect her livelihood -- then called her doctor, who succeeded in having the pharmacy in the southern US state release the medicine.

"I picked it up a couple hours later, but I felt violated," she told AFP, explaining she had had a hysterectomy six years ago, and that her lack of recent contraceptive history may have led the pharmacist to suspect she was pregnant.

Stories of people facing similar struggles have come to light in the weeks since the United States Supreme Court overturned Roe v Wade on June 24, highlighting an overlooked consequence of new state-level bans or severe restrictions on abortion.

It's not yet clear how widespread the cases are, but national organizations including the Lupus Foundation of America and the American College of Rheumatology said they were aware of such concerns and asking people affected to come forward.

"The Arthritis Foundation supports unencumbered access to and coverage of FDA-approved drugs for managing arthritis in alignment with scientific and clinical guidelines, as well as evidence-based medical recommendations," the organization said.

The issue centers on methotrexate, a drug which tempers inflammation and is commonly used against autoimmune conditions including inflammatory arthritis, psoriasis and lupus.

Methotrexate stops cell division and is given in higher doses as a cancer drug.

It can also sometimes be used in medical abortions, though not as frequently as the Food and Drug Administration-approved combination of two other drugs, mifepristone and misoprostol.

Nevertheless, many states have passed laws carrying threats of legal action against health care workers and pharmacies providing methotrexate.

- 'It's terrifying' -

Another woman contacted by AFP, a 20-year-old university student from Ohio, said she has had a methotrexate prescription since 2020 to treat her lupus, which affects her kidney and liver and causes joint pain.

A pharmacist at a national chain told her they were "no longer accepting prescriptions for methotrexate unless it was for the FDA-approved use of (treating) breast cancer, or the patient was not presumably fertile," she said.

She tried again, without success, to fill her prescription at a family-owned pharmacy, and this week got a letter from her doctor's office stating the practice would no longer be prescribing methotrexate because of the number of patients having difficulty accessing it.

Though the first pharmacy later changed its position, the experience left her "annoyed and angry," she said.

A third woman, 48-year-old Jennifer Crow, a writer and produce gardener in Tellico Plains, Tennessee, told AFP she received an automated call from CVS saying her methotrexate refill had been declined "pending provider approval."

Crow said Methotrexate had helped her enormously in managing her inflammatory arthritis, allowing her to roll out of bed and get dressed without severe pain, and walk without a cane for the first time in years.

Though her doctor was able to resolve the situation, Crow, who has also had a hysterectomy, said she was worried for other chronic illness patients who didn't have the same access to resources that she does.

In statements to AFP, national pharmacy chains CVS and Walmart confirmed they were working to adhere to new state regulations in light of the high court's decision to revoke the constitutional right to an abortion.

CVS added: "We encourage providers to include their diagnosis on the prescriptions they write to help ensure patients have quick and easy access to medications."

Alisa Vidulich, policy director of the Arthritis Foundation, told AFP she was hopeful the situation might be remedied quickly as medical professionals and pharmacies developed new guidelines.

"But that may not actually be the case in all states and it may in fact turn into a longer term issue," she acknowledged.

Melissa, the nurse, said she was incensed at the double standard that allowed one of her best friends, who is a man, to get his methotrexate prescription filled right away with no questions asked.

"We're headed in the wrong direction and it's terrifying. I have two daughters. I don't want to see this," she said.

M.Fujitav--JT